INTRODUCTION {#sec1-1}
============

*Candida* species are the fourth leading cause of nosocomial blood stream infections (BSI) in the United States. The incidence and prevalence of candidemia is increasing in many other countries also.\[[@ref1]\] In India, the picture is not very clear due to lack of multicentric studies. Although, there are a few studies indicating the increasing trend of candidemia in some tertiary care hospitals.\[[@ref2]\] The mortality rate associated with candidemia worldwide is also high, ranging from 10--49%.\[[@ref1]\]

More than 17 different species of *Candida* have been reported to be etiologic agents of invasive candidiasis in humans. Although more than 90% of invasive candidiasis is attributed to five species *C. albicans, C. glabrata, C. tropicalis, C. parapsilosis* and *C. krusei*, the list of reported species continues to grow.\[[@ref1]\] Although *Candida albicans* still remains the most common cause of candidemia worldwide, there has been an increase in the isolation of non-albicans *Candida* species.\[[@ref1]\] In the few available studies from India, *Candida tropicalis* has been the most common species of *Candida* isolated from blood.\[[@ref2][@ref3]\]

With the emergence of non-albicans species of *Candida* worldwide, especially *Candida glabrata* and *Candida krusei*, antifungal drug resistance has become a major cause of concern in the management of candidemia. Resistance to fluconazole and other triazoles is very high among these species of *Candida*.\[[@ref4]\] Other non-albicans *Candida* species like *Candida tropicalis* and *Candida parapsilosis* have been found to have variable susceptibility to the azole group of drugs. There have been a few reports of *Candida* species being resistant to amphotericin B and echinocandins also.\[[@ref5][@ref6]\]

A number of phenotypic methods have been developed for the speciation of *Candida* isolates which includes dalmau technique, sugar assimilation and fermentation, growth of characteristic colonies of various *Candida* species on tetrazolium reduction medium, CHROMagar etc. These standard phenotypic methods require about 48 to 72 h or sometimes even more for the speciation of *Candida* isolates and are also not very sensitive or specific.

The rapid detection and identification of *Candida* isolates from blood samples is very important for the proper management of patients having candidemia. The use of PCR as a method for diagnosis of candidemia has been proved to have a much greater sensitivity than these methods.\[[@ref7]\] Here we report the use of polymerase chain reaction -- restricted fragment length polymorphism (PCR-RFLP) as a rapid, easy and cost-effective method for the rapid identification of five *Candida* species from blood isolates of ICU patients.

MATERIALS AND METHODS {#sec1-2}
=====================

Standard Strains: *Candida glabrata* obtained from National Culture Collection of Pathogenic Fungi (NCCPF), PGI (Chandigarh) and ATCC strains of *Candida albicans* (90028), *Candida tropicalis* (750), *Candida parapsilosis* (90018), and *Candida krusei* (6258) were used as a standard strains.

Clinical isolates {#sec2-1}
-----------------

Totally 39 consecutive clinical isolates were collected from blood samples of patients from various intensive care units (ICUs) for a one-year period at Sri Ramachandra Medical Center, Chennai, Tamil Nadu, India. All the isolates were screened and identified using conventional culture and microscopic method. The isolates were cultured on Sabouraud\'s Dextrose Agar (SDA) and used for molecular analysis.

DNA isolation {#sec2-2}
-------------

DNA extraction was performed from all the clinical isolates and standard strains by in-house method. Briefly, 400 μl of lysis buffer (10mM TRIS, pH - 8), 1mM EDTA (pH - 8), 3% SDS and 100 mM NaCl) was taken in a 1.5-ml centrifuge tube. A loop full of *Candida* culture was suspended in the lysis buffer and heated in water bath at 100°C for 1 min. Equal volume of Phenol: Chloroform was added to it and mixed well. It was centrifuged at 10,000 rpm for 10 min. The aqueous layer was transferred to a fresh centrifuge tube and the step was repeated once by adding chloroform to the supernatant. The DNA was precipitated by equal volume of cold isopropyl alcohol, centrifuged and washed with 70% ethanol. The pellet was re-suspended in 30 μl of TE buffer and stored at -20°C until use.

PCR assay {#sec2-3}
---------

The master mix was prepared containing 25 μl of PCR mix (GeNei, Bangalore), 1 μl of forward (ITS-1) and reverse primer (ITS-4) (GeNei, Bangalore), 1 μl of template DNA and the volume made up to 50 μl with sterile nuclease-free water. The reaction mix was kept in the thermocycler (Eppendorf). The program was performed as follows: initial denaturation at 95°C for 5 min, denaturation at 95°C for 30 sec, annealing at 56 °C for 30 sec, extension at 72 °C for 30 sec and final extension at 72 °C for 5 min.

RFLP {#sec2-4}
----

Two μl of enzyme buffer, 5 Units of *Msp* I (GeNei, Banglore) enzyme and 10 μl of PCR product were added in a 200-μl PCR tube and the volume was made up to 20 μl with nuclease-free water. The reaction mix was incubated at 37°C for 1 h.

Agarose gel electrophoresis {#sec2-5}
---------------------------

PCR products and RFLP products were electrophoresed in 1.5% and 2.0% agarose gel respectively, stained with Ethidium bromide (0.5 μg/ml) and visualized under UV light and photographed.

RESULTS {#sec1-3}
=======

The PCR assay was able to amplify the ITS-1 and ITS-2 region of all 39 isolates using universal primers ITS-1 and ITS-4. Amplicon size of 500-800bp was obtained from five medically important *Candida* species (*C. tropicalis, C. albicans, C. parapsilosis, C. krusei and C. glabrata*) \[Figures [1a](#F1){ref-type="fig"} and [2a](#F2){ref-type="fig"}\]. The restriction enzyme *Msp* I was used for RFLP technique as experimented by Mirhendi *et al*.,\[[@ref8]\] it produced two bands in each species except *C. parapsilosis* since it does not have restriction site specific for *Msp* I \[Figure [1b](#F1){ref-type="fig"} and [2b](#F2){ref-type="fig"}\]. The banding patterns are different from each other and hence it is easy to distinguish one species from another \[Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}\].

![(a) PCR products from standard strains of *Candida* species. Lanes 1-5: *C. albicans* (ATCC 90028), *C. tropicalis* (ATCC 750), *C. parapsilosis* (90018), *C. glabrata* (pure strain from NCCPF) and *C. krusei* (6258), respectively. Lanes M: 100 bp DNA ladder. (b) RFLP products from standard strains of *Candida* species. Lanes 1-5: *C. albicans* (ATCC 90028), *C. tropicalis* (ATCC 750), *C. parapsilosis* (90018), *C. glabrata* (pure strain from NCCPF) and *C. krusei* (6258), respectively. Lanes M: 100 bp DNA ladder.](JLP-4-1-g001){#F1}

![(a) PCR products from representative test strains of *Candida* species. Lanes 1-5: *C. albicans, C. tropicalis, C. parapsilosis, C. glabrata* and *C. krusei*, respectively. Lanes M: 100 bp DNA ladder. (b) RFLP products from representative test strains of *Candida* species. Lanes 1-5: *C. albicans, C. tropicalis, C. parapsilosis, C. glabrata* and *C. krusei,* respectively. Lanes M: 100 bp DNA ladder.](JLP-4-1-g002){#F2}

###### 

Size of ITS1-ITS2 products for *Candida* species before and after digestion with *Msp* I

![](JLP-4-1-g003)

###### 

Species distribution of *Candida* isolates from blood of ICU patients by polymerase chain reaction -- restricted fragment length polymorphism

![](JLP-4-1-g004)

DISCUSSION {#sec1-4}
==========

Rapid detection of *Candida* from blood stream infections is very essential for management of candidemia and to decrease the mortality rate associated with it. Currently used phenotypic methods may take 48 to 72 h to properly diagnose *Candida* isolates to the species level. Due to the limitations of phenotypic methods, molecular methods especially polymerase chain reaction (PCR) is being increasingly used for the rapid detection of *Candida* from blood. PCR has been found to have a much higher sensitivity in detecting candidemia than conventional phenotypic methods.\[[@ref7]\]

Many other molecular methods have also been developed for the rapid diagnosis of *Candida* species like RAPD (Random amplified polymorphic DNA), DNA sequence analysis, mitochondrial large subunit ribosomal RNA gene sequencing and real-time PCR.\[[@ref9]--[@ref11]\] But these methods are expensive and need skilled workers trained in such techniques.

In our study, PCR-RFLP was done for 39 *Candida* isolates from blood samples of ICU patients. The ITS1-5.8S-ITS2 rDNA region from genomic DNA of several species of *Candida* was amplified by PCR. RFLP was done for the amplified products using the *Msp* I restriction enzyme. All the isolates were correctly identified to the species level. Five species of *Candida* were detected from blood isolates of ICU patients in our study (*C.tropicalis, C. albicans, C. parapsilosis, C. glabrata, C. krusei*).

PCR-RFLP has been found to be a rapid and reliable method to speciate *Candida* isolates in other studies also. In a study by Shokohi *et al*., from Iran, *Candida* species have been identified in cancer patients by PCR-RFLP using two restriction enzymes (*Bln* I, *Msp* I).\[[@ref12]\] In another similar study from Iran, Mirhendi *et al*., have developed a one-enzyme PCR-RFLP assay for identification of six medically important *Candida* species.\[[@ref8]\] PCR-RFLP has also been used to speciate *Candida* isolates causing intraocular infections by Okhravi *et al*.\[[@ref13]\]

In our study, we found PCR-RFLP to be a rapid, easy to handle and cost-effective procedure which can be used to speciate *Candida* isolates from blood samples. The whole procedure of PCR-RFLP from *Candida* isolates can be completed within 7 h as compared to 48--72 h needed for phenotypic methods to speciate the isolates. This will give clinicians valuable time to decide on the empirical treatment of candidemia before antifungal sensitivity reports are available. For example, *C. krusei* is intrinsically resistant to fluconazole and *C. glabrata* is also usually resistant to fluconazole. So, patients having candidemia caused by such species can be started empirically on amphotericin B or echinocandins.

CONCLUSION {#sec1-5}
==========

PCR-RFLP is an easy, rapid and highly valuable tool which can be used in routine diagnostic laboratories to speciate *Candida* isolates obtained from blood. This rapid method of speciation will help clinicians to decide on empirical therapy in candidemia cases before antifungal susceptibility results are available.
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